SCHEMBL2373894

SCHEMBL2373894

O=C(NCc1cccnc1)c1csc(Nc2ccncn2)n1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.55
MMP13 P45452 1/20 0.55
POLB P06746 2/20 0.51
ROCK2 O75116 1/20 0.49
ROCK1 Q13464 1/20 0.49
TSHR P16473 2/20 0.47
RAB9A P51151 4/20 0.46
NPC1 O15118 3/20 0.46
TP53 P04637 2/20 0.46
KMT2A Q03164 3/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
SLC40A1 Q9NP59 1/20 0.46
NPSR1 Q6W5P4 1/20 0.45
MEN1 O00255 2/20 0.44
ALDH1A1 P00352 2/20 0.44
KDM4E B2RXH2 1/20 0.44
PKM P14618 1/20 0.44
USP2 O75604 1/20 0.44
LMNA P02545 1/20 0.44
MAPT P10636 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31681851 1.00 HTT (0.55) HTTMMP13POLBROCK2ROCK1
SCHEMBL29072859 0.90 MMP13 (0.48) HTTMMP13ROCK2ROCK1TSHR
SCHEMBL669856 0.90 MMP13 (0.48) HTTMMP13ROCK2ROCK1TSHR
SCHEMBL24139180 0.84 SMN1; SMN2 (0.53) HTTMMP13POLBROCK2ROCK1
SCHEMBL2374577 0.83 MPL (0.46) MMP13ROCK2ROCK1SMN1; SMN2
SCHEMBL31681838 0.82 ROCK1 (0.54) MMP13ROCK2ROCK1KMT2AMAPT
SCHEMBL2373426 0.82 ROCK1 (0.54) MMP13ROCK2ROCK1KMT2AMAPT
SCHEMBL2374833 0.82 MPL (0.52) MMP13RAB9ANPC1KMT2AMEN1
SCHEMBL12254348 0.82 CYP1A2 (0.41) HTTPOLBROCK2ROCK1TSHR
SCHEMBL2373405 0.82 CYP1A2 (0.58) HTTPOLBROCK2ROCK1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4585589-A2 STEM CELL CULTURES The Scripps Research Institute (US) 2025-07-16 EP disclosed
EP-4296270-B1 A COMPOSITION COMPRISING STEM CELL CULTURES SCRIPPS RESEARCH INST (US) 2025-06-18 EP disclosed
EP-4296270-A2 A COMPOSITION COMPRISING STEM CELL CULTURES The Scripps Research Institute (US) 2023-12-27 EP disclosed
EP-3936508-B1 A COMPOSITION COMPRISING STEM CELL CULTURES SCRIPPS RESEARCH INST (US) 2023-12-06 EP disclosed
EP-3936508-A1 A COMPOSITION COMPRISING STEM CELL CULTURES The Scripps Research Institute (US) 2022-01-12 EP disclosed
EP-3936508-A1 A COMPOSITION COMPRISING STEM CELL CULTURES The Scripps Research Institute (US) 2022-01-12 EP disclosed
US-20210403862-A1 METHODS OF ENHANCING CELL SURVIVAL OF STEM CELLS THE SCRIPPS RESEARCH INSTITUTE 2021-12-30 US disclosed
US-20210403862-A1 METHODS OF ENHANCING CELL SURVIVAL OF STEM CELLS THE SCRIPPS RESEARCH INSTITUTE 2021-12-30 US disclosed
EP-3623374-B1 STEM CELL CULTURES SCRIPPS RESEARCH INST (US) 2021-09-08 EP disclosed
EP-3623374-B1 STEM CELL CULTURES SCRIPPS RESEARCH INST (US) 2021-09-08 EP disclosed
US-20110294761-A1 STEM CELL CULTURES THE SCRIPPS RESEARCH INSTITUTE (US) 2011-12-01 US disclosed
US-20110294761-A1 STEM CELL CULTURES THE SCRIPPS RESEARCH INSTITUTE (US) 2011-12-01 US disclosed
US-20110294761-A1 STEM CELL CULTURES THE SCRIPPS RESEARCH INSTITUTE (US) 2011-12-01 US disclosed
US-8044201-B2 Stem cell cultures THE SCRIPPS RESEARCH INSTITUTE (US) 2011-10-25 US disclosed
US-8044201-B2 Stem cell cultures THE SCRIPPS RESEARCH INSTITUTE (US) 2011-10-25 US disclosed
US-8044201-B2 Stem cell cultures THE SCRIPPS RESEARCH INSTITUTE (US) 2011-10-25 US disclosed
US-20110224233-A1 STEM CELL CULTURES THE SCRIPPS RESEARCH INSTITUTE (US) 2011-09-15 US disclosed
US-20110224233-A1 STEM CELL CULTURES THE SCRIPPS RESEARCH INSTITUTE (US) 2011-09-15 US disclosed
US-20110224233-A1 STEM CELL CULTURES THE SCRIPPS RESEARCH INSTITUTE (US) 2011-09-15 US disclosed
WO-2010065721-A1 STEM CELL CULTURES THE SCRIPPS RESEARCH INSTITUTE (US) 2010-06-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110294761-A1 STEM CELL CULTURES NES, CD44, MCL1 HTT 918/4885MMP13 2052/4885POLB 2398/4885
US-20210403862-A1 METHODS OF ENHANCING CELL SURVIVAL OF STEM CELLS MCL1, BCL2, BCLAF1 HTT 1702/4885MMP13 2573/4885POLB 968/4885
US-20110224233-A1 STEM CELL CULTURES NES, CD44, MCL1 HTT 918/4885MMP13 2052/4885POLB 2398/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.